Abstract:Introduction Recently, several genome-wide association studies (GWAS) have identified novel single nucleotide polymorphisms (SNPs) associated with breast cancer risk. However, most of the studies were conducted among Caucasians and only one from Chinese. Methods In the current study, we first tested whether 15 SNPs identified by previous GWAS were also breast cancer marker SNPs in this Chinese population. Then, we grouped the marker SNPs, and modeled them with clinical risk factors, to see the usage of these factors in breast cancer risk assessment. Two methods (risk factors counting and odds ratio (OR) weighted risk scoring) were used to evaluate the cumulative effects of the five significant SNPs and two clinical risk factors (age at menarche and age at first live birth). Results Five SNPs located at 2q35, 3p24, 6q22, 6q25 and 10q26 were consistently associated with breast cancer risk in both testing set (878 cases and 900 controls) and validation set (914 cases and 967 controls) samples. Overall, all of the five SNPs contributed to breast cancer susceptibility in a dominant genetic model (2q35, rs13387042: adjusted OR = 1.26, P = 0.006; 3q24.1, rs2307032: adjusted OR = 1.24, P = 0.005; 6q22.33, rs2180341: adjusted OR = 1.22, P = 0.006; 6q25.1, rs2046210: adjusted OR = 1.51, P = 2.40 × 10 -8 ; 10q26.13, rs2981582: adjusted OR = 1.31, P = 1.96 × 10 -4 ). Risk score analyses (area under the curve (AUC): 0.649, 95% confidence interval (CI): 0.631 to 0.667; sensitivity = 62.60%, specificity = 57.05%) presented better discrimination than that by risk factors counting (AUC: 0.637, 95% CI: 0.619 to 0.655; sensitivity = 62.16%, specificity = 60.03%) ( P < 0.0001). Absolute risk was then calculated by the modified Gail model and an AUC of 0.658 (95% CI = 0.640 to 0.676) (sensitivity = 61.98%, specificity = 60.26%) was obtained for the combination of five marker SNPs, age at menarche and age at first live birth. Conclusions This study shows that five GWAS identified variants were also consistently validated in this Chinese population and combining these genetic variants with other risk factors can improve the risk predictive ability of breast cancer. However, more breast cancer associated risk variants should be incorporated to optimize the risk assessment.

Genetic Variants at 1p11.2 and Breast Cancer Risk: A Two-Stage Study in Chinese Women

Genetic Variants at Chromosome 9p21, 10p15 and 10q22 and Breast Cancer Susceptibility in a Chinese Population

Evaluation of Breast Cancer Susceptibility Loci in Chinese Women.

Assessing Interactions Between The Association Of Common Genetic Variant At 1p11 (Rs11249433) And Hormone Receptor Status With Breast Cancer Risk

The Association of CASC16 Variants with Breast Cancer Risk in a Northwest Chinese Female Population

Genetic Variants at 14q24.1 and Breast Cancer Susceptibility: a Fine-Mapping Study in Chinese Women

luation of Breast Cancer Susceptibility Loci in B & P nese Women

Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs

Genetic Variants at 5p12 and Risk of Breast Cancer in Han Chinese

Breast Cancer Risk Assessment with Five Independent Genetic Variants and Two Risk Factors in Chinese Women

Genetic Variants of 6q25 and Breast Cancer Susceptibility: a Two-Stage Fine Mapping Study in a Chinese Population

Association of Multiple Genetic Variants with Breast Cancer Susceptibility in the Han Chinese Population

Identification of A Functional Genetic Variant at 16q12.1 for Breast Cancer Risk: Results from the Asia Breast Cancer Consortium

Genome-Wide Association Study Identifies Breast Cancer Risk Variant at 10q21.2: Results from the Asia Breast Cancer Consortium

Association Between Mitogen-Activated Protein Kinase Kinase Kinase 1 Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis of 20 Case-Control Studies

Evaluation of Functional Genetic Variants at 6q25.1 and Risk of Breast Cancer in a Chinese Population

Identification of novel susceptibility markers for the risk of overall breast cancer as well as subtypes defined by hormone receptor status in the Chinese population

Genome-wide Association Study in East Asians Identifies Novel Susceptibility Loci for Breast Cancer.

Association Between 15 Known or Potential Breast Cancer Susceptibility Genes and Breast Cancer Risks in Chinese Women

Rare Coding Variants and Breast Cancer Risk: Evaluation of Susceptibility Loci Identified in Genome-Wide Association Studies

Single-nucleotide Polymorphisms in PSCA and the Risk of Breast Cancer in a Chinese Population